Engin Ulukaya Selected Research

Histone Deacetylases (Histone Deacetylase)

1/2021

Combination of Histone Deacetylase Inhibitor with Cu(II) 5,5-diethylbarbiturate Complex Induces Apoptosis in Breast Cancer Stem Cells: A Promising Novel Approach.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Engin Ulukaya Research Topics

Disease

45	Neoplasms (Cancer) 05/2022 - 04/2004
30	Breast Neoplasms (Breast Cancer) 06/2021 - 12/2009
11	Lung Neoplasms (Lung Cancer) 09/2021 - 09/2006
10	Non-alcoholic Fatty Liver Disease 01/2011 - 02/2007
8	Necrosis 01/2021 - 11/2007
6	Prostatic Neoplasms (Prostate Cancer) 11/2020 - 01/2013
6	Carcinoma (Carcinomatosis) 10/2017 - 06/2007
5	Neoplasm Metastasis (Metastasis) 05/2022 - 12/2011
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2021 - 10/2011
3	Colonic Neoplasms (Colon Cancer) 08/2018 - 01/2015
3	Liver Diseases (Liver Disease) 11/2009 - 02/2009
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 05/2020
2	Triple Negative Breast Neoplasms 01/2019 - 02/2017
2	Ascites 07/2016 - 03/2015
2	Myocardial Ischemia (Ischemic Heart Diseases) 10/2014 - 12/2009
2	Inflammation (Inflammations) 10/2014 - 12/2010
2	Liver Cirrhosis (Hepatic Cirrhosis) 11/2010 - 03/2009
2	Insulin Resistance 01/2010 - 11/2009
2	Fatty Liver 11/2009 - 11/2007
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2009 - 06/2009
2	Infections 04/2009 - 11/2007
1	Ataxia Telangiectasia (Louis Bar Syndrome) 06/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019

Drug/Important Bio-Agent (IBA)

17	PalladiumIBA 09/2021 - 10/2011
12	Adenosine Triphosphate (ATP)IBA 05/2022 - 02/2008
11	Keratin-18 (Keratin 18)IBA 01/2021 - 02/2007
10	Pharmaceutical PreparationsIBA 05/2022 - 04/2004
10	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2007
10	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 10/2010
8	CaspasesIBA 01/2021 - 06/2007
7	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 01/2013
7	PlatinumIBA 01/2019 - 10/2011
5	Proteins (Proteins, Gene)FDA Link 05/2022 - 11/2009
5	5- (2'- naphthyl)- 7- 4- chlorophenyl- (2,3,6,8- tetrahydro)pyrrolo- (3,4- e)(1,4)- diazepine- 6- thioxo- 8- (1H,7H)oneIBA 07/2016 - 10/2011
4	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 06/2011
4	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2017 - 12/2009
3	AntigensIBA 01/2019 - 06/2007
3	Caspase 3 (Caspase-3)IBA 01/2018 - 02/2016
3	MetalsIBA 02/2017 - 11/2014
3	saccharinate(2,2'- 6',2'- terpyridine)palladium(II)IBA 02/2015 - 10/2011
3	Bortezomib (Velcade)FDA Link 01/2015 - 10/2012
2	Histone Deacetylase InhibitorsIBA 01/2021 - 01/2018
2	Propidium (Propidium Iodide)IBA 01/2021 - 01/2018
2	Chloroquine (Aralen)FDA LinkGeneric 01/2021 - 08/2020
2	Valproic Acid (Depakote)FDA LinkGeneric 01/2021 - 01/2018
2	Chalcone (Benzalacetophenone)IBA 06/2020 - 08/2017
2	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2020 - 01/2020
2	Histones (Histone)IBA 01/2019 - 01/2018
2	RNA (Ribonucleic Acid)IBA 01/2019 - 11/2007
2	Biological ProductsIBA 01/2018 - 08/2016
2	DNA (Deoxyribonucleic Acid)IBA 12/2016 - 04/2008
2	ImmunosorbentsIBA 08/2016 - 11/2010
2	EnzymesIBA 08/2016 - 11/2010
2	Interleukin-6 (Interleukin 6)IBA 07/2015 - 04/2008
2	Proteasome InhibitorsIBA 01/2015 - 10/2012
2	FenretinideIBA 05/2014 - 07/2013
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2011 - 06/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2011 - 09/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2010 - 04/2008
2	Indicators and Reagents (Reagents)IBA 10/2010 - 09/2006
2	Receptor for Advanced Glycation End ProductsIBA 01/2010 - 06/2009
2	Triglycerides (Triacylglycerol)IBA 01/2010 - 11/2009
1	Amino Acids FDA Link 05/2022
1	LipidsIBA 05/2022
1	phenyl di-n-pentylphosphinateIBA 09/2021
1	MicellesIBA 09/2021
1	AcidsIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA 01/2021
1	Oxidoreductases (Dehydrogenase)IBA 01/2021
1	Pyruvic Acid (Pyruvate)IBA 01/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	Etoposide (VP 16)FDA LinkGeneric 11/2020
1	poly-N-isopropylacrylamideIBA 11/2020
1	Antimalarials (Antimalarial Agents)IBA 08/2020
1	barbituric acid (barbiturate)IBA 08/2020
1	protoapigenoneIBA 06/2020
1	ferroceneIBA 06/2020
1	AntioxidantsIBA 01/2020
1	QuercetinIBA 01/2020
1	LigandsIBA 01/2020
1	GlycosidesIBA 03/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	Canertinib (CI 1033)IBA 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	Hormones (Hormone)IBA 01/2019
1	NaphthoquinonesIBA 01/2019
1	EthaneIBA 08/2018
1	Coloring Agents (Dyes)IBA 01/2018
1	FITC-annexin A5IBA 01/2018
1	celastrol methyl esterIBA 01/2018

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 06/2021 - 06/2007
10	Therapeutics 06/2021 - 06/2007
2	Lasers (Laser) 01/2022 - 01/2009
2	Neoadjuvant Therapy 01/2019 - 06/2011
1	Investigational Therapies (Experimental Therapy) 09/2021
1	Molecular Targeted Therapy 01/2021
1	Radiotherapy 01/2019